Objective:This study aimed to compare the efficacy of anti-CD19 chimeric antigen receptor T cells(CAR-T cells)versus chemotherapy plus donor lymphocyte infusion(chemo-DLI)for treating relapsed CD 19-positive B-cell ac...Objective:This study aimed to compare the efficacy of anti-CD19 chimeric antigen receptor T cells(CAR-T cells)versus chemotherapy plus donor lymphocyte infusion(chemo-DLI)for treating relapsed CD 19-positive B-cell acute lymphoblastic leukemia(B-ALL)after allogeneic hematopoietic stem cell transplantation(allo-HSCT).Methods:Clinical data of 43 patients with B-ALL who relapsed after allo-HSCT were retrospectively analyzed.Twenty-two patients were treated with CAR-T cells(CAR-T group),and 21 with chemotherapy plus DLI(chemo-DLI group).The complete remission(CR)and minimal residual disease(MRD)-negative CR rates,leukemia-free survival(LFS)rate,overall survival(OS)rate,and incidence of acute graft-versus-host disease(aGVHD),cytokine release syndrome(CRS)and immune effector cell-associated neurotoxicity syndrome(ICANS)were compared between the two groups.Results:The CR and MRD-negative CR rates in the CAR-T group(77.3%and 61.5%)were significantly higher than those in the chemo-DLI group(38.1%and 23.8%)(P=0.008 and P=0.003).The 1-and 2-year LFS rates in the CAR-T group were superior to those in the chemo-DLI group:54.5%and 50.0%vs.9.5%and 4.8%(P=0.0001 and P=0.00004).The 1-and 2-year OS rates in the CAR-T versus chemo-DLI group were 59.1%and 54.5%vs.19%and 9.5%(P=0.011 and P=0.003).Six patients(28.6%)with grade 2-4 aGVHD were identified in the chemo-DLI group.Two patients(9.1%)in the CAR-T group developed grade 1-2 aGVHD.Nineteen patients(86.4%)developed CRS in the CAR-T group,comprising grade 1-2 CRS in 13 patients(59.1%)and grade 3 CRS in 6 patients(27.3%).Two patients(9.1%)developed grade 1-2 ICANS.Conclusion:Donor-derived anti-CD19 CAR-T-cell therapy may be better,safer,and more effective than chemo-DLI for B-ALL patients who relapse after allo-HSCT.展开更多
Hormone receptor(HR)-positive breast cancer(BC)is the most common subtype of BC and some patients with such tumors experience recurrences.Endocrine-based therapy(ET)(e.g.,tamoxifen,aromatase inhibitors(AIs),and fulves...Hormone receptor(HR)-positive breast cancer(BC)is the most common subtype of BC and some patients with such tumors experience recurrences.Endocrine-based therapy(ET)(e.g.,tamoxifen,aromatase inhibitors(AIs),and fulvestrant)that has improved outcomes in such patients represents the initial therapy for women with HR-positive/human epidermal growth factor receptor 2(HER2)-negative BC(considering no evidence of visceral crisis).However,the resistance to ET can occur in almost 50%of HR-positive BCs.In order to improve outcomes of patients with HR-positive metastatic BC,new treatment strategies are required.One such therapy is the new class of medications,cyclin-dependent kinase(CDK)4/6 inhibitors,that have improved the outcomes in such patients(both endocrine-sensitive and endocrine-resistant).This article presents evidence from the main clinical trials,which led to the approval of palbociclib,ribociclib,and abemaciclib.These three CDK 4/6 inhibitors have shown a significant improvement of the progression-free survival(PFS)in patients with HR-positive/HER2-negative metastatic BC when used in combination with selected ETs.In addition,some important patient management considerations,when choosing a particular CDK 4/6 inhibitor for an individual patient are presented.Furthermore,a need to find biomarkers for CDK 4/6 inhibitor sensitivity,efficacy,and resistance,to be able to precisely select the best patientcandidates for this treatment is highlighted.展开更多
The moxa therapy is a popular traditional hyperthermia therapy in East Asia. The moxa is made from dried mugwort (Artemisiaargyi). The moxa is usually put on a meridian point and then is burnt on to obtain a hyperther...The moxa therapy is a popular traditional hyperthermia therapy in East Asia. The moxa is made from dried mugwort (Artemisiaargyi). The moxa is usually put on a meridian point and then is burnt on to obtain a hyperthermic stimulation to the skin. However, very few researches have been studied in the effects and mechanism of the moxa therapy. Therefore, in this study, we gave the moxa stimulation to healthy subjects. In the moxa group, the moxa was lit on the ST36 (Zusanli: an acupuncture point in anterior tibialis of the leg) for 5 minutes. Their responses were traced with electrogastrogram (EGG) and assessed the change of gastric function. At the same time, their heart rate (HR) was recorded and observed to study the mechanism of moxa treatment. And then their results were compared with those of the control group. After the moxa stimulation, EGG showed significant increase and stayed 3.0 - 3.1 cpm while HR prominently decreased. On the other hand, the control group did not indicate such results. Those results are common to the re-sponse of acupuncture-like stimulation by the reflex arc which consists of receptor, sensory neuron, central nervous system, motor neuron and effector. It may be explained as below: the elements of the acupuncture-like stimulation and the moxa are pain and hyperthermia respectively and they both are received by polymodal receptors. Thus the moxa stimulation applied on ST36 may be ef-fective to enhance stomach function.展开更多
Background Chemokines and their receptors have been a research focus in transplantation immunology. Chemokines and their receptors play a role in lymphocyte recruitment and differentiation process. This study aimed to...Background Chemokines and their receptors have been a research focus in transplantation immunology. Chemokines and their receptors play a role in lymphocyte recruitment and differentiation process. This study aimed to observe whether IL-4 and IL-10 may regulate the expression of chemokine receptors CCR3, CCR5 and CXCR3 on CD4^+ T cells in CBA/J×DBA/2 mouse model and to explore the role of CCR3, CCR5, CXCR3 in immune tolerance in pregnancy. Methods The mouse model of spontaneous abortion (CBA/J×DBA/2) and the normal pregnant mouse model (CBA/J×BALB/c) were used. CBA/J×DBA/2 mice were injected with IL-4 (CBA/J×DBA/2-IL-4), IL-4 and IL-10 (CBA/J×DBA/2-IL-4+IL-10), or normal saline (CBA/J×DBA/2-NS) as a control. The expression of CCR3, CCR5 and CXCR3 on CD4^+ T cells from mouse peripheral blood was measured by the double-labelled FCM method, and the embryo resorption rate was also examined. Results The embryo resorption rate in the CBA/J×DBA/2 group without any treatment was significantly higher than that in the CBA/J×BALB/c group (17.9% vs 3.7%, P 〈0.01). The embryo resorption rate in the CBA/J×DBA/2 group immunized with IL-4 or IL-4 together with IL-10 was significantly decreased, compared with that in the control and NS groups respectively. CCR3 expression on CD4^+ T cells in the CBA/J×DBA/2 group without any treatment was significantly lower than that in the CBA/J×BALB/c group (0.3738±0.3575 vs 1.2190±0.2772, P 〈0.01); both CCR5 (3.0900±1.5603 vs 1.2390±0.6361, P〈0.01) and CXCR3 (2.4715±0.9074 vs 0.9200±0.5585, P 〈0.01) expressions on CD4^+ T cells of the CBA/J×DBA/2 group without any treatment were significantly higher than those of the CBA/J×BALB/c group. Significant up-regulation of CCR3 and down-regulation of CXCR3 were found in the CBA/J×DBA/2 group treated with IL-4 (CCR3: 2.0360±0.6944, CXCR3: 1.3510±0.5263, P〈0.01) or IL-4 and IL-10 (CCR3: 1.8160±1.0947, CXCR3:1.0940±0.7168, P〈0.01). Because of the CCR5, IL-4 and IL-10 (1.9400±0.8504 vs 3.0900±1.5603, P 〈0.05), but IL-4 alone (2.5310±1.3595 vs 3.0900±1.5603, P 〉0.05) treatment significantly decreased the expression of CCR5 in CBA/J×DBA/2. Conclusions The abnormal expression of CCR3, CCR5 and CXCR3 on CD4^+ T cells may play an important role in the pathogenesis of spontaneous abortion. The pregnancy immune tolerance may be induced through selective induction of CCR3, CCR5 and CXCR3 expressions by IL-4 together with IL-10.展开更多
Background Previous studies have shown that local immune cells in the feto-maternal interface are recruited from peripheral blood, and that chemokines and their receptors play an initial and key role in this recruitme...Background Previous studies have shown that local immune cells in the feto-maternal interface are recruited from peripheral blood, and that chemokines and their receptors play an initial and key role in this recruitment process. In this study, we aimed to determine whether spontaneous abortion is associated with the expression of chemokine receptors CCR3, CCR5, and CXCR3 on CD4^+ T cells. Methods Peripheral blood, spleen, and thymus were collected from the spontaneous abortion mouse model CBA/JxDBA/2 (SA group, n=14), the normal pregnant mouse model CBA/JxBALB/c (NP group, n=13), and normal non-pregnant CBA/J mice (NNP group, n=11). The number of chemokine receptors CCR3, CCR5, and CXCR3 expressed on CD4^+ T cells was measured by double-label flow cytometry (FCM) method. Results In peripheral blood, the SA group had significantly lower CCR3 expression (P 〈0.01) and higher CCR5 and CXCR3 expression (P 〈0.01) on CD4^+ T cells than did the NP group. But comparing these chemokines between the SA and NNP groups, there was no significant difference (P 〉0.05). In spleen, the SA group expressed significantly lower CCR3 expression (P 〈0.01) and higher CCR5 and CXCR3 expression (P 〈0.05) on CD4^+ T cells than did the NP group. When compared with the NNP group, the SA group had significantly higher CCR3 expression (P 〈0.01), but was not statistically different with regards to the other two chemokines (P 〉0.05). In thymus, the SA group had significantly lower CCR3 expression (P 〈0.05) and higher CXCR3 expression (P 〈0.05) on CD4^+ T cells than the NP group, with no significant difference in CCR5 expression (P 〉0.05). Compared with the NNP group, the SA group had higher CCR3 expression (P 〈0.01), but there was no statistical difference in CXCR3 and CCR5 expression (P 〉0.05) between the two groups. Conclusion The abnormal expression of CCR3, CCR5 and CXCR3 on CD4^+ T cells may play an important role in the pathogenesis of spontaneous abortion.展开更多
目的探讨雄激素受体(androgen receptor,AR)在HER-2+(HR-),HER-2+(HR+)及三阴性(triplenegative breast cancer,TNBC)乳腺癌中的表达及其与临床病理特征的关系。方法收集2014年5月至2017年4月手术切除的260例HER-2+(HR+),HER-2+(HR-)和...目的探讨雄激素受体(androgen receptor,AR)在HER-2+(HR-),HER-2+(HR+)及三阴性(triplenegative breast cancer,TNBC)乳腺癌中的表达及其与临床病理特征的关系。方法收集2014年5月至2017年4月手术切除的260例HER-2+(HR+),HER-2+(HR-)和三阴性乳腺癌标本,采用免疫组织化学方法检测AR的表达情况,采用χ~2检验分析AR在三个分型中的表达特点及其与临床病理特征的关系,采用Kaplan-Meier生存分析曲线显示AR在三个分型乳腺癌患者中的预后价值。结果AR的表达与组织分级、组织学类型、组织是否存在坏死相关(P<0.05),与ER、PR、HER-2、p53的表达有密切联系(P<0.01)。AR在HER-2+(HR-),HER-2+(HR+)和三阴性乳腺癌中的表达率分别为85.71%(66/77),74.03%(57/77)和29.25%(31/106),三组间的差异具有统计学意义(P<0.01)。生存曲线显示,AR阳性无病生存率高于AR阴性(P<0.05),AR阳性和AR阴性总生存率差异无统计学意义。结论AR的表达与HER-2+(HR-),HER-2+(HR+)及三阴性乳腺癌患者的组织分级、组织学类型、组织坏死以及预后等临床病理参数具有较好的相关性。展开更多
基金supported by grants from the National Natural Science Foundation of China(No.82020108004)the Hospital-level Clinical Innovation Military-Civilian Special Project of Army Medical University(No.2018JSLC0020)+1 种基金Chongqing Science and Technology Innovation Leading Talent(No.CSTCCXLJRC201718)Natural Science Foundation of Chongqing Innovation Group Science Program(No.cstc2021jcyj-cxttX0001).
文摘Objective:This study aimed to compare the efficacy of anti-CD19 chimeric antigen receptor T cells(CAR-T cells)versus chemotherapy plus donor lymphocyte infusion(chemo-DLI)for treating relapsed CD 19-positive B-cell acute lymphoblastic leukemia(B-ALL)after allogeneic hematopoietic stem cell transplantation(allo-HSCT).Methods:Clinical data of 43 patients with B-ALL who relapsed after allo-HSCT were retrospectively analyzed.Twenty-two patients were treated with CAR-T cells(CAR-T group),and 21 with chemotherapy plus DLI(chemo-DLI group).The complete remission(CR)and minimal residual disease(MRD)-negative CR rates,leukemia-free survival(LFS)rate,overall survival(OS)rate,and incidence of acute graft-versus-host disease(aGVHD),cytokine release syndrome(CRS)and immune effector cell-associated neurotoxicity syndrome(ICANS)were compared between the two groups.Results:The CR and MRD-negative CR rates in the CAR-T group(77.3%and 61.5%)were significantly higher than those in the chemo-DLI group(38.1%and 23.8%)(P=0.008 and P=0.003).The 1-and 2-year LFS rates in the CAR-T group were superior to those in the chemo-DLI group:54.5%and 50.0%vs.9.5%and 4.8%(P=0.0001 and P=0.00004).The 1-and 2-year OS rates in the CAR-T versus chemo-DLI group were 59.1%and 54.5%vs.19%and 9.5%(P=0.011 and P=0.003).Six patients(28.6%)with grade 2-4 aGVHD were identified in the chemo-DLI group.Two patients(9.1%)in the CAR-T group developed grade 1-2 aGVHD.Nineteen patients(86.4%)developed CRS in the CAR-T group,comprising grade 1-2 CRS in 13 patients(59.1%)and grade 3 CRS in 6 patients(27.3%).Two patients(9.1%)developed grade 1-2 ICANS.Conclusion:Donor-derived anti-CD19 CAR-T-cell therapy may be better,safer,and more effective than chemo-DLI for B-ALL patients who relapse after allo-HSCT.
文摘Hormone receptor(HR)-positive breast cancer(BC)is the most common subtype of BC and some patients with such tumors experience recurrences.Endocrine-based therapy(ET)(e.g.,tamoxifen,aromatase inhibitors(AIs),and fulvestrant)that has improved outcomes in such patients represents the initial therapy for women with HR-positive/human epidermal growth factor receptor 2(HER2)-negative BC(considering no evidence of visceral crisis).However,the resistance to ET can occur in almost 50%of HR-positive BCs.In order to improve outcomes of patients with HR-positive metastatic BC,new treatment strategies are required.One such therapy is the new class of medications,cyclin-dependent kinase(CDK)4/6 inhibitors,that have improved the outcomes in such patients(both endocrine-sensitive and endocrine-resistant).This article presents evidence from the main clinical trials,which led to the approval of palbociclib,ribociclib,and abemaciclib.These three CDK 4/6 inhibitors have shown a significant improvement of the progression-free survival(PFS)in patients with HR-positive/HER2-negative metastatic BC when used in combination with selected ETs.In addition,some important patient management considerations,when choosing a particular CDK 4/6 inhibitor for an individual patient are presented.Furthermore,a need to find biomarkers for CDK 4/6 inhibitor sensitivity,efficacy,and resistance,to be able to precisely select the best patientcandidates for this treatment is highlighted.
文摘The moxa therapy is a popular traditional hyperthermia therapy in East Asia. The moxa is made from dried mugwort (Artemisiaargyi). The moxa is usually put on a meridian point and then is burnt on to obtain a hyperthermic stimulation to the skin. However, very few researches have been studied in the effects and mechanism of the moxa therapy. Therefore, in this study, we gave the moxa stimulation to healthy subjects. In the moxa group, the moxa was lit on the ST36 (Zusanli: an acupuncture point in anterior tibialis of the leg) for 5 minutes. Their responses were traced with electrogastrogram (EGG) and assessed the change of gastric function. At the same time, their heart rate (HR) was recorded and observed to study the mechanism of moxa treatment. And then their results were compared with those of the control group. After the moxa stimulation, EGG showed significant increase and stayed 3.0 - 3.1 cpm while HR prominently decreased. On the other hand, the control group did not indicate such results. Those results are common to the re-sponse of acupuncture-like stimulation by the reflex arc which consists of receptor, sensory neuron, central nervous system, motor neuron and effector. It may be explained as below: the elements of the acupuncture-like stimulation and the moxa are pain and hyperthermia respectively and they both are received by polymodal receptors. Thus the moxa stimulation applied on ST36 may be ef-fective to enhance stomach function.
基金This study was supported by a grant from the Natural Science Foundation of Shanghai, China (No. 07ZR14072).
文摘Background Chemokines and their receptors have been a research focus in transplantation immunology. Chemokines and their receptors play a role in lymphocyte recruitment and differentiation process. This study aimed to observe whether IL-4 and IL-10 may regulate the expression of chemokine receptors CCR3, CCR5 and CXCR3 on CD4^+ T cells in CBA/J×DBA/2 mouse model and to explore the role of CCR3, CCR5, CXCR3 in immune tolerance in pregnancy. Methods The mouse model of spontaneous abortion (CBA/J×DBA/2) and the normal pregnant mouse model (CBA/J×BALB/c) were used. CBA/J×DBA/2 mice were injected with IL-4 (CBA/J×DBA/2-IL-4), IL-4 and IL-10 (CBA/J×DBA/2-IL-4+IL-10), or normal saline (CBA/J×DBA/2-NS) as a control. The expression of CCR3, CCR5 and CXCR3 on CD4^+ T cells from mouse peripheral blood was measured by the double-labelled FCM method, and the embryo resorption rate was also examined. Results The embryo resorption rate in the CBA/J×DBA/2 group without any treatment was significantly higher than that in the CBA/J×BALB/c group (17.9% vs 3.7%, P 〈0.01). The embryo resorption rate in the CBA/J×DBA/2 group immunized with IL-4 or IL-4 together with IL-10 was significantly decreased, compared with that in the control and NS groups respectively. CCR3 expression on CD4^+ T cells in the CBA/J×DBA/2 group without any treatment was significantly lower than that in the CBA/J×BALB/c group (0.3738±0.3575 vs 1.2190±0.2772, P 〈0.01); both CCR5 (3.0900±1.5603 vs 1.2390±0.6361, P〈0.01) and CXCR3 (2.4715±0.9074 vs 0.9200±0.5585, P 〈0.01) expressions on CD4^+ T cells of the CBA/J×DBA/2 group without any treatment were significantly higher than those of the CBA/J×BALB/c group. Significant up-regulation of CCR3 and down-regulation of CXCR3 were found in the CBA/J×DBA/2 group treated with IL-4 (CCR3: 2.0360±0.6944, CXCR3: 1.3510±0.5263, P〈0.01) or IL-4 and IL-10 (CCR3: 1.8160±1.0947, CXCR3:1.0940±0.7168, P〈0.01). Because of the CCR5, IL-4 and IL-10 (1.9400±0.8504 vs 3.0900±1.5603, P 〈0.05), but IL-4 alone (2.5310±1.3595 vs 3.0900±1.5603, P 〉0.05) treatment significantly decreased the expression of CCR5 in CBA/J×DBA/2. Conclusions The abnormal expression of CCR3, CCR5 and CXCR3 on CD4^+ T cells may play an important role in the pathogenesis of spontaneous abortion. The pregnancy immune tolerance may be induced through selective induction of CCR3, CCR5 and CXCR3 expressions by IL-4 together with IL-10.
基金This study was supported by a grant from the Natural Science Foundation of Shanghai (No.07ZR14072).We are grateful to Yael Saden Barach (Albert Einstein College of Medicine, New York) for editing this manuscript.
文摘Background Previous studies have shown that local immune cells in the feto-maternal interface are recruited from peripheral blood, and that chemokines and their receptors play an initial and key role in this recruitment process. In this study, we aimed to determine whether spontaneous abortion is associated with the expression of chemokine receptors CCR3, CCR5, and CXCR3 on CD4^+ T cells. Methods Peripheral blood, spleen, and thymus were collected from the spontaneous abortion mouse model CBA/JxDBA/2 (SA group, n=14), the normal pregnant mouse model CBA/JxBALB/c (NP group, n=13), and normal non-pregnant CBA/J mice (NNP group, n=11). The number of chemokine receptors CCR3, CCR5, and CXCR3 expressed on CD4^+ T cells was measured by double-label flow cytometry (FCM) method. Results In peripheral blood, the SA group had significantly lower CCR3 expression (P 〈0.01) and higher CCR5 and CXCR3 expression (P 〈0.01) on CD4^+ T cells than did the NP group. But comparing these chemokines between the SA and NNP groups, there was no significant difference (P 〉0.05). In spleen, the SA group expressed significantly lower CCR3 expression (P 〈0.01) and higher CCR5 and CXCR3 expression (P 〈0.05) on CD4^+ T cells than did the NP group. When compared with the NNP group, the SA group had significantly higher CCR3 expression (P 〈0.01), but was not statistically different with regards to the other two chemokines (P 〉0.05). In thymus, the SA group had significantly lower CCR3 expression (P 〈0.05) and higher CXCR3 expression (P 〈0.05) on CD4^+ T cells than the NP group, with no significant difference in CCR5 expression (P 〉0.05). Compared with the NNP group, the SA group had higher CCR3 expression (P 〈0.01), but there was no statistical difference in CXCR3 and CCR5 expression (P 〉0.05) between the two groups. Conclusion The abnormal expression of CCR3, CCR5 and CXCR3 on CD4^+ T cells may play an important role in the pathogenesis of spontaneous abortion.
文摘目的探讨雄激素受体(androgen receptor,AR)在HER-2+(HR-),HER-2+(HR+)及三阴性(triplenegative breast cancer,TNBC)乳腺癌中的表达及其与临床病理特征的关系。方法收集2014年5月至2017年4月手术切除的260例HER-2+(HR+),HER-2+(HR-)和三阴性乳腺癌标本,采用免疫组织化学方法检测AR的表达情况,采用χ~2检验分析AR在三个分型中的表达特点及其与临床病理特征的关系,采用Kaplan-Meier生存分析曲线显示AR在三个分型乳腺癌患者中的预后价值。结果AR的表达与组织分级、组织学类型、组织是否存在坏死相关(P<0.05),与ER、PR、HER-2、p53的表达有密切联系(P<0.01)。AR在HER-2+(HR-),HER-2+(HR+)和三阴性乳腺癌中的表达率分别为85.71%(66/77),74.03%(57/77)和29.25%(31/106),三组间的差异具有统计学意义(P<0.01)。生存曲线显示,AR阳性无病生存率高于AR阴性(P<0.05),AR阳性和AR阴性总生存率差异无统计学意义。结论AR的表达与HER-2+(HR-),HER-2+(HR+)及三阴性乳腺癌患者的组织分级、组织学类型、组织坏死以及预后等临床病理参数具有较好的相关性。